Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
83.07M | 106.04M | 104.51M | 60.40M | 45.16M | Gross Profit |
14.40M | 18.73M | 21.09M | 12.24M | 7.33M | EBIT |
1.09M | 4.41M | 8.37M | 3.51M | -1.99M | EBITDA |
-323.37K | 6.58M | 8.27M | 3.93M | -1.89M | Net Income Common Stockholders |
-3.85M | 909.41K | 8.64M | 1.32M | -5.15M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
0.00 | 0.00 | -1.94M | -7.48M | -1.78M | Total Assets |
58.17M | 68.37M | 78.50M | 43.80M | 26.29M | Total Debt |
17.70M | 31.00M | 39.59M | 23.89M | 12.63M | Net Debt |
17.70M | 31.00M | 41.53M | 31.36M | 14.42M | Total Liabilities |
38.56M | 45.83M | 56.09M | 32.08M | 15.73M | Stockholders Equity |
19.61M | 22.54M | 22.41M | 11.72M | 10.56M |
Cash Flow | Free Cash Flow | |||
9.97M | 12.00M | -10.67M | -9.26M | 10.22M | Operating Cash Flow |
10.39M | 12.69M | -8.57M | -9.22M | 10.22M | Investing Cash Flow |
-414.09K | -676.64K | -2.10M | 40.11K | 1.43K | Financing Cash Flow |
-9.97M | -12.01M | 10.67M | 9.18M | -10.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | C$390.40M | 6.16 | 11.38% | 3.74% | 11.02% | 102.23% | |
74 Outperform | C$147.23M | 4.72 | 16.11% | ― | 18.29% | -94.32% | |
65 Neutral | C$279.30M | 151.92 | -3.90% | ― | -5.98% | -121.37% | |
57 Neutral | $7.06B | 3.07 | -3.45% | 5.82% | 0.59% | -50.58% | |
54 Neutral | C$9.78M | 0.39 | -3.83% | 24.72% | -86.21% | ― | |
54 Neutral | C$273.13M | 15.02 | 3.00% | ― | -5.50% | -88.55% | |
46 Neutral | C$6.87M | ― | -13.50% | ― | -21.66% | -523.55% |
Bri-Chem Corp. reported a significant decline in its financial performance for the fourth quarter of 2024, with consolidated sales dropping by 23% to $20.6 million due to decreased U.S. drilling activity. The company’s adjusted EBITDA and operating earnings also saw substantial decreases, alongside a notable reduction in working capital, which was impacted by a loan classification change. Despite these challenges, Bri-Chem received a waiver for a covenant breach from its lender, indicating ongoing financial adjustments and potential future stability.